Can Phone-Based Motivational Interviewing Improve Medication Adherence to Antiplatelet Medications After a Coronary Stent Among Racial Minorities? A Randomized Trial

Journal of General Internal Medicine

Volumn 30, Issue 4, 2015, Pages 469-475

  Palacio, Ana M ^a,b   Uribe, Claudia ^c   Hazel Fernandez, Leslie ^c   Li, Hua ^a,b   Tamariz, Leonardo J ^a,b   Garay, Sylvia D ^a   Carrasquillo, Olveen ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Formerly of Comprehensive Health Insights Inc   (United States)

Author keywords

antiplatelet medications; coronary stents; medication adherence; minorities; motivational interviewing

Indexed keywords

ANTITHROMBOCYTIC AGENT;

AGED; BLACK PERSON; CONTROLLED STUDY; CORONARY BLOOD VESSEL; ETHNOLOGY; FEMALE; HISPANIC; HUMAN; INTERVIEW; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MINORITY GROUP; MOTIVATIONAL INTERVIEWING; PATHOLOGY; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; STENT; SURGERY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CORONARY VESSELS; FEMALE; HISPANIC AMERICANS; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MINORITY GROUPS; MOTIVATIONAL INTERVIEWING; PLATELET AGGREGATION INHIBITORS; STENTS;

EID: 84939953846     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-014-3139-8     Document Type: Article

References (52)

1. Grines C. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation (New York, N.Y.). 2007;115(6):813–8.
2. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113(24):2803–9.
3. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126–30.
4. Petersen JL, Barron JJ, Hammill BG, et al. Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore integrated research database. Am Heart J. 2010;159(3):462–470.e1.
5. Brar SS, ten Berg J, Marcucci R, et al. Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol. 2011;58(19):1945–54.
6. Roth GA, Morden NE, Zhou W, Malenka DJ, Skinner J. Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent. Circ Cardiovasc Qual Outcomes. 2012;5(1):103–12.
7. World Health Organization. Noncommunicable diseases and mental health: Progress report 2002–2003. Geneva:; 2003.
8. Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940–8.
9. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38(2):303–12.
10. Rodriguez F, Cannon CP, Steg PG, et al. Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH registry. Clin Cardiol. 2013;36(12):721–7.
11. Sonel AF, Good CB, Mulgund J, et al. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines?). Circulation. 2005;111(10):1225–32.
12. Palacio AM, De Marchena E, Parris D, Li H, Florez H, O’Neill W. Impact of lack of clopidogrel use in stent related myocardial infarction. Journal of the American College of Cardiology. 2008;51:236–70.
13. Kumar RS, Douglas PS, Peterson ED, et al. Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked national cardiovascular data registry and centers for medicare & medicaid services payer databases. Circulation. 2013;127(13):1395–403.
14. Kumbhani DJ, Steg PG, Cannon CP, et al. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis. Am J Med. 2013;126(8):693–700.e1.
15. World Health Organization. Adherence to long term therapies:Evidence for action. 2003.
16. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005(4):CD000011.
17. Boland GM, Chang GJ, Haynes AB, et al. Association between adherence to national comprehensive cancer network treatment guidelines and improved survival in patients with colon cancer. Cancer. 2013;119(8):1593–601.
18. Easthall C, Song F, Bhattacharya D. A meta-analysis of cognitive-based behaviour change techniques as interventions to improve medication adherence. BMJ Open. 2013;3(8): doi:10.1136/bmjopen,2013-002749.
19. Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the united states: a systematic review. Ann Intern Med. 2012;157(11):785–95.
20. Palacio AM, Tamariz LJ, Uribe C, et al. Can claims-based data be used to recruit black and hispanic subjects into clinical trials? Health Serv Res. 2011.
21. Wei II, Virnig BA, John DA, Morgan RO. Using a spanish surname match to improve identification of hispanic women in medicare administrative data. Health Serv Res. 2006;41(4 Pt 1):1469–81.
22. Elliott MN. Using the census Bureau’s surname list to improve estimates of race/ethnicity and associated disparities. Health Serv Outcomes Res. 2009;9(2):69–83.
23. Fiscella K, Fremont AM. Use of geocoding and surname analysis to estimate race and ethnicity. Health Serv Res. 2006;41(4 Pt 1):1482–500.
24. Armstrong MJ, Mottershead TA, Ronksley PE, Sigal RJ, Campbell TS, Hemmelgarn BR. Motivational interviewing to improve weight loss in overweight and/or obese patients: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2011;12(9):709–23.
25. Hettema JE, Hendricks PS. Motivational interviewing for smoking cessation: a meta-analytic review. J Consult Clin Psychol. 2010;78(6):868–84.
26. Heckman CJ, Egleston BL, Hofmann MT. Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Tob Control. 2010;19(5):410–6.
27. Thompson DR, Chair SY, Chan SW, Astin F, Davidson PM, Ski CF. Motivational interviewing: a useful approach to improving cardiovascular health? J Clin Nurs. 2011;20(9–10):1236–44.
28. Ogedegbe G, Chaplin W, Schoenthaler A, et al. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens. 2008;21(10):1137–43.
29. Pradier C, Bentz L, Spire B, et al. Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials. 2003;4(2):121–31.
30. Holstad MM, Essien JE, Ekong E, Higgins M, Teplinskiy I, Adewuyi MF. Motivational groups support adherence to antiretroviral therapy and use of risk reduction behaviors in HIV positive nigerian women: a pilot study. Afr J Reprod Health. 2012;16(3):14–27.
31. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–90; discussion 1073.
32. Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004;57(10):1107–10.
33. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105–16.
34. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7–8):1280–88.
35. Steiner JF. Rethinking adherence. Ann Intern Med. 2012;157(8):580–5.
36. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.
37. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004;148(1):99–104.
38. Fillenbaum GG, Burchett BM, Blazer DG. Identifying a national death index match. Am J Epidemiol. 2009;170(4):515–8.
39. Chew LD, Griffin JM, Partin MR, et al. Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med. 2008;23(5):561–6.
40. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.
41. Deyo RA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613.
42. Needham DM, Scales DC, Laupacis A, Pronovost PJ. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care. 2005;20(1):12–9.
43. Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005;55(513):305–12.
44. Heisler M, Hofer TP, Klamerus ML, et al. Study protocol: the adherence and intensification of medications (AIM) study--a cluster randomized controlled effectiveness study. Trials. 2010;11:95.
45. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.
46. Konkle-Parker DJ, Erlen JA, Dubbert PM, May W. Pilot testing of an HIV medication adherence intervention in a public clinic in the deep south. J Am Acad Nurse Pract. 2012;24(8):488–98.
47. Golin CE, Earp J, Tien HC, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr. 2006;42(1):42–51.
48. Interian A, Lewis-Fernandez R, Gara MA, Escobar JI. A randomized-controlled trial of an intervention to improve antidepressant adherence among latinos with depression. Depress Anxiety. 2013;30(7):688–96.
49. Clarkesmith DE, Pattison HM, Lip GY, Lane DA. Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial. PLoS One. 2013;8(9):e74037.
50. Nover C, Jackson SS. Primary care-based educational interventions to decrease risk factors for metabolic syndrome for adults with major psychotic and/or affective disorders: a systematic review. Syst Rev. 2013;2:116,4053-2-116.
51. Crouch R, Wilson A, Newbury J. A systematic review of the effectiveness of primary health education or intervention programs in improving rural women’s knowledge of heart disease risk factors and changing lifestyle behaviours. Int J Evid Based Healthc. 2011;9(3):236–45.
52. Feres F, Costa RA, Abizaid A, et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA. 2013;310(23):2510–22.